Malignant fibrous histiocytoma of bone associated with type-1 neurofibromatosis: A case report

Journal of Bone and Joint Surgery

Volumn 87, Issue 2, 2005, Pages 399-403

  Papagelopoulos, Panayiotis J ^a   Mavrogenis, Andreas F ^b   Galanis, Evanthia C ^c   Chloros, George D ^b   Papaparaskeva, Kleo Th ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Mayo Clinic ^*  (Greece)

^c MAYO CLINIC   (United States)

^d ATHENS MEDICAL CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ADULT; ARTICLE; BONE BIOPSY; BONE CANCER; BONE EROSION; BONE PROSTHESIS; CAFE AU LAIT SPOT; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMUR TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PRIORITY JOURNAL;

EID: 13444250878     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.D.02117     Document Type: Article

References (45)

1. Dorfman HD, Czerniak B. Bone tumors. St. Louis: Mosby; 1998. p 815-54.
2. Goodnough CP, Kuhlmann RP, Stark E. Von Recklinghausen's neurofibromatosis; with nonosteogenic fibroma. NY State J Med. 1975;75:2407-9.
3. Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI, Eldridge R. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990;113:39-52.
4. National Institutes of Health. Neurofibromatosis. NIH Consensus Statements Online. 1987 Jul 13-15;6:1-19. http://consensus.nih.gov/cons/064/ 064_statement.htm.
5. Cinamon U, Avinoach I, Harell M. Neurofibromatosis type 1, hyperparathyroidism, and osteosarcoma: interplay? Eur Arch Otorhinolaryngol. 2002;259:540-2.
6. Reynolds RM, Browning GG, Nawroz I, Campbell IW. Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1. Lancet. 2003;361:1552-4.
7. Crawford AH. Neurofibromatosis in children. Am Fam Physician. 1978;17:163-70.
8. Izumi AK, Rosato FE, Wood MG. Von Recklinghausen's disease associated with multiple neurolemomas. Arch Dermatol. 1971;104:172-6.
9. Sordillo PP, Helson L, Hadju SI, Magill GB, Kosloff C, Golbey RB, Beattie EJ. Malignant schwannoma - clinical characteristics, survival, and response to therapy. Cancer. 1981;47:2503-9.
10. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer. 1990;66:1253-65.
11. Bullock MJ, Bedard YC, Bell RS, Kandel R. Intraosseous malignant peripheral nerve sheath tumor. Report of a case and review of the literature. Arch Pathol Lab Med. 1995;11:367-70.
12. Terry DG, Sauser DD, Gordon MD. Intraosseous malignant peripheral nerve sheath tumor in a patient with neurofibromatosis. Skeletal Radiol. 1998;27:346-9.
13. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St Louis: Mosby; 1995.
14. Kini H, Mukthabai B, Ajithkumar M. Malignant fibrous histocytoma of bone in neurofibromatosis - a case report. Indian J Pathol Microbiol. 2001;44:57-8.
15. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol. 1992;16:694-707.
16. Vandenbroucke I, van Doorn R, Callens T, Cobben JM, Starink TM, Messiaen L. Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet. 2004;114:284-90.
17. Friedman JM, Fialkow PJ, Greene CL, Weinberg MN. Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis. J Natl Cancer Inst. 1982;69:1289-92.
18. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whalen JM, Yandell DW, Farmer GE, Frieman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA. 1990;87:5435-9.
19. Merel P, Hoang-Xuan K, Sanson M, Bijlsma E, Rouleau G, Laurent-Puig P, Pulst S, Baser M, Lenoir G, Sterkers JM, Philippon J, Resche F, Mautner VF, Fischer G, Hulsebos T, Aurias A, Delattre O, Thomas G. Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer. 1995;12:117-27.
20. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, Rojiani AM, Maria BL, Muir D, Wallace MR. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer. 2000;28:425-31.
21. Martignetti JA, Gelb BD, Pierce H, Picci P, Desnick RJ. Malignant fibrous histiocytoma: inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22 - evidence for a common genetic defect. Genes Chromosomes Cancer. 2000;27:191-5.
22. Papagelopoulos PJ, Galanis EC, Sim FH, Unni KK. Clinicopathologic features, diagnosis, and treatment of malignant fibrous histiocytoma of bone. Orthopedics. 2000;23:59-67.
23. Schajowicz F. Tumors and tumorlike lesions of bones and joints. New York: Springer; 1994. p 427-38.
24. Feldman F, Norman D. Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology. 1972;104:497-508.
25. Spanier SS, Enneking WF, Enriquez P. Primary malignant fibrous histiocytoma of bone. Cancer. 1975;36:2084-98.
26. Huvos AG. Primary malignant fibrous histiocytoma of bone; clinicopathologic study of 18 patients. NY State J Med. 1976;76:552-659.
27. Huvos AG. Bone tumors: diagnosis, treatment, and prognosis. 2nd ed. Philadelphia: WB Saunders; 1991.
28. Kennedy C, Stoker DJ. Malignant fibrous histiocytoma complicating chronic osteomyelitis. Clin Radiol. 1990;41:435-6.
29. Sanerkin NG, Woods CG. Fibrosarcomata and malignant fibrous histiocytomata arising in relation to enchondromata. J Bone Joint Surg Br. 1979;61:366-72.
30. Spanier SS. Malignant fibrous histiocytoma of bone. Orthop Clin North Am. 1977;8:947-61.
31. Mirra JM. Bone tumors, diagnosis and treatment. Philadelphia: JB Lippincott; 1980.
32. Huvos AG, Woodard HQ, Heilweil M. Postradiation malignant fibrous histiocytoma of bone. A clinicopathologic study of 20 patients. Am J Surg Pathol. 1986;10:9-18.
33. Anract P, de Pinieux G, Jeanrot C, Babinet A, Forest M, Tomeno B. Malignant fibrous histiocytoma at the site of a previously treated aneurysmal bone cyst: a case report. J Bone Joint Surg Am. 2002;84:106-11.
34. Ward JJ, Thornbury DD, Lemons JE, Dunham WK. Metal-induced sarcoma. A case report and literature review. Clin Orthop. 1990;252:299-306.
35. Halpern J, Kopolovic J, Catane R. Malignant fibrous histiocytoma developing in irradiated sacral chordoma. Cancer. 1984;53:2661-2.
36. Forest M. Malignant fibrous histiocytoma. In: Forest M, Tomeno B, Vanel D, editors. Orthopedic surgical pathology: diagnosis of tumors and pseudotumoral lesions of bone and joints. New York: Churchill Livingstone; 1998. p 323-33.
37. Ghandur-Mnaymneh L, Zych G, Mnaymneh W. Primary malignant fibrous histiocytoma of bone: report of six cases with ultrastructural study and analysis of the literature. Cancer. 1982;49:698-707.
38. Capanna R, Bertoni F, Bacchini P, Bacci G, Guerra A, Campanacci M. Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer. 1984;54:177-87.
39. Yuen WW, Saw D. Malignant fibrous histiocytoma of bone. J Bone Joint Surg Am. 1985;67:482-6.
40. Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am J Surg Pathol. 1985;9:853-71.
41. Bacci G, Ferrari S, Bertoni F, Mercuri M, Forni C, Sottili S, Gasbarrini A, Tienghi A, Cesari M, Campanacci M. Neoadjuvant chemotherapy for osseous malignat fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen. J Chemother. 1997;9:293-9.
42. Bacci G, Picci P, Mercuri M, Bertoni F, Ferrari S. Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone. Clin Orthop. 1998;346:178-89.
43. Bielack SS, Schroeders A, Fuchs N, Bacci G, Bauer HC, Mapeli S, Tomeno B, Winkler K. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand. 1999;70:353-60.
44. Bramwell VH, Steward WP, Nooij M, Whelan J, Craft AW, Grimer RJ, Taminau AH, Cannon SR, Malcolm AJ, Hogendoorn PC, Uscinska B, Kirkpatrick AL, Machin D, Van Glabbeke MM. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study. J Clin Oncol. 1999;17:3260-9.
45. Nishida J, Sim FH, Wenger DE, Unni KK. Malignant fibrous histiocytoma of bone. A clinicopathologic study of 81 patients. Cancer. 1997;79:482-93.